Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $6.63 billion. The enterprise value is $10.58 billion.
| Market Cap | 6.63B |
| Enterprise Value | 10.58B |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 63.06 million shares outstanding. The number of shares has decreased by -15.23% in one year.
| Shares Outstanding | 63.06M |
| Shares Change (YoY) | -15.23% |
| Shares Change (QoQ) | -10.23% |
| Owned by Insiders (%) | 2.78% |
| Owned by Institutions (%) | 96.81% |
| Float | 61.25M |
Valuation Ratios
The trailing PE ratio is 21.62 and the forward PE ratio is 5.07. JAZZ's PEG ratio is 0.84.
| PE Ratio | 21.62 |
| Forward PE | 5.07 |
| PS Ratio | 1.72 |
| Forward PS | 1.57 |
| PB Ratio | 1.79 |
| P/FCF Ratio | 6.55 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.09, with an EV/FCF ratio of 10.46.
| EV / Earnings | 31.97 |
| EV / Sales | 2.75 |
| EV / EBITDA | 9.09 |
| EV / EBIT | 20.37 |
| EV / FCF | 10.46 |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 1.56.
| Current Ratio | 2.27 |
| Quick Ratio | 1.62 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | 4.95 |
| Debt / FCF | 5.70 |
| Interest Coverage | 1.85 |
Financial Efficiency
Return on equity (ROE) is 9.20% and return on invested capital (ROIC) is 7.62%.
| Return on Equity (ROE) | 9.20% |
| Return on Assets (ROA) | 2.90% |
| Return on Capital (ROIC) | 7.62% |
| Revenue Per Employee | $1.37M |
| Profits Per Employee | $118,141 |
| Employee Count | 2,800 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.64 |
Taxes
| Income Tax | -92.92M |
| Effective Tax Rate | -39.06% |
Stock Price Statistics
The stock price has decreased by -15.35% in the last 52 weeks. The beta is 0.62, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -15.35% |
| 50-Day Moving Average | 108.79 |
| 200-Day Moving Average | 119.62 |
| Relative Strength Index (RSI) | 40.51 |
| Average Volume (20 Days) | 824,703 |
Short Selling Information
The latest short interest is 2.56 million, so 4.05% of the outstanding shares have been sold short.
| Short Interest | 2.56M |
| Short Previous Month | 3.41M |
| Short % of Shares Out | 4.05% |
| Short % of Float | 4.17% |
| Short Ratio (days to cover) | 2.78 |
Income Statement
In the last 12 months, JAZZ had revenue of $3.84 billion and earned $330.79 million in profits. Earnings per share was $4.86.
| Revenue | 3.84B |
| Gross Profit | 3.44B |
| Operating Income | 518.73M |
| Pretax Income | 237.88M |
| Net Income | 330.79M |
| EBITDA | 1.16B |
| EBIT | 519.28M |
| Earnings Per Share (EPS) | $4.86 |
Balance Sheet
The company has $1.82 billion in cash and $5.77 billion in debt, giving a net cash position of -$3.95 billion or -$62.61 per share.
| Cash & Cash Equivalents | 1.82B |
| Total Debt | 5.77B |
| Net Cash | -3.95B |
| Net Cash Per Share | -$62.61 |
| Equity (Book Value) | 3.70B |
| Book Value Per Share | 58.62 |
| Working Capital | 1.98B |
Cash Flow
In the last 12 months, operating cash flow was $1.04 billion and capital expenditures -$27.04 million, giving a free cash flow of $1.01 billion.
| Operating Cash Flow | 1.04B |
| Capital Expenditures | -27.04M |
| Free Cash Flow | 1.01B |
| FCF Per Share | $16.17 |
Margins
Gross margin is 89.53%, with operating and profit margins of 13.50% and 8.61%.
| Gross Margin | 89.53% |
| Operating Margin | 13.50% |
| Pretax Margin | 6.19% |
| Profit Margin | 8.61% |
| EBITDA Margin | 30.29% |
| EBIT Margin | 13.51% |
| FCF Margin | 26.32% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 15.23% |
| Shareholder Yield | 15.23% |
| Earnings Yield | 4.99% |
| FCF Yield | 15.26% |
Analyst Forecast
The average price target for JAZZ is $189.93, which is 80.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $189.93 |
| Price Target Difference | 80.73% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 6.15% |
| EPS Growth Forecast (5Y) | 32.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.33 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 7 |